Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Antimetabolite dose intensity and adverse outcomes in children with acute lymphoblastic leukemia: a COG-AALL03N1 report

Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anne Angiolillo, David S. Dickens, Joseph P. Neglia, Yaddanapudi Ravindranath, Amanda Termuhlen, F. Lennie Wong, Wendy Landier, Smita Bhatia

Blood (2024) 144 (22): 2327–2335.

https://doi.org/10.1182/blood.2024024455

Published: 2024

Includes: Supplemental data

Journal Articles

Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children’s Oncology Group study AALL03N1 report

Aman Wadhwa, Yanjun Chen, Lindsey Hageman, Anna Hoppmann, Anne Angiolillo, David S. Dickens, Joseph P. Neglia, Yaddanapudi Ravindranath, A. Kim Ritchey, Amanda Termuhlen, F. Lennie Wong, Wendy Landier, Smita Bhatia

Blood (2023) 142 (3): 221–229.

https://doi.org/10.1182/blood.2023019631

Published: 2023

Includes: Supplemental data

Journal Articles

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Blood (2017) 130 (Supplement 1): 98.

https://doi.org/10.1182/blood.V130.Suppl_1.98.98

Published: 2017

Journal Articles

Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children’s Oncology Group (COG) Study (AALL03N1)

Lindsey Hageman, Wendy Landier, PhD, R.N., Yanjun Chen, MS, Heeyoung Kim, M.S., Nancy Kornegay, M.S., William E. Evans, PharmD, Bruce C. Bostrom, MD, Jacqueline Casillas, MD, M.S.H.S., David Dickens, MD, Anne Angiolillo, MD, Glen Lew, MD, Kelly Maloney, MD, Leo Mascarenhas, Arthur K. Ritchey, MD, Amanda Termuhlen, MD, William L. Carroll, MD, Mary V. Relling, PharmD, F. Lennie Wong, Smita Bhatia, PhD

Blood (2014) 124 (21): 369.

https://doi.org/10.1182/blood.V124.21.369.369

Published: 2014

Journal Articles

High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1)

Smita Bhatia, Ph.D., Wendy Landier, Ph.D., R.N., Lindsey Hageman, Can-Lan Sun, Heeyoung Kim, M.S., Nancy Kornegay, M.S., William E. Evans, PharmD, Bruce C. Bostrom, MD, Jacqueline Casillas, M.D., M.S.H.S, Anne Angiolillo, MD, Glen Lew, MD, Kelly Maloney, MD, Leo Mascarenhas, Jane Meza, Ph.D., A. Kim Ritchey, MD, Amanda Termuhlen, MD, William L. Carroll, MD, F. Lennie Wong, PhD, Mary V. Relling, PharmD

Blood (2013) 122 (21): 59.

https://doi.org/10.1182/blood.V122.21.59.59

Published: 2013

Journal Articles

Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia

Fatih M. Uckun, Sanjive Qazi, Ingrid Cely, Kazim Sahin, Anoush Shahidzadeh, Ibrahim Ozercan, Qian Yin, Paul Gaynon, Amanda Termuhlen, Jianjun Cheng, Seang Yiv

Blood (2013) 121 (21): 4348–4354.

https://doi.org/10.1182/blood-2012-11-470633

Published: 2013

Includes: Supplemental data

Journal Articles

Meta-Analysis of Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) with Comparison to a Historical Control (HC).

Blood (2010) 116 (21): 3481.

https://doi.org/10.1182/blood.V116.21.3481.3481

Published: 2010

Journal Articles

Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF): Results of a Treatment IND Expanded Access Protocol

Blood (2010) 116 (21): 906.

https://doi.org/10.1182/blood.V116.21.906.906

Published: 2010

Journal Articles

Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control.

Paul Richardson, M.D., Marcie Tomblyn, MD, MS, Nancy Kernan, M.D., Joel A. Brochstein, MD, Shin Mineishi, MD, Amanda Termuhlen, MD, Sally Arai, MD, Stephan A. Grupp, MD, PhD, Eva Guinan, M.D., Paul L. Martin, MD, PhD, Selim Corbacioglu, MD, Ernst Holler, M.D., Ralph D'Agostino, Ph.D., Joseph Massaro, Ph.D., Alison L. Hannah, MD, Massimo Iacobelli, M.D., Robert J Soiffer, MD

Blood (2009) 114 (22): 654.

https://doi.org/10.1182/blood.V114.22.654.654

Published: 2009

Journal Articles

High-Dose Methotrexate and Early Intensification of Therapy Do Not Improve 3 Year EFS in Children and Adolescents with Disseminated Lymphoblastic Lymphoma. Results of the Randomized Arms of COG A5971

Minnie Abromowitch, MD, Amanda Termuhlen, MD, Myron Chang, PhD, Sherrie L. Perkins, MD, PhD, Thomas Gross, MD, PhD, Howard J. Weinstein, MD, Jonathan Finlay, MD

Blood (2008) 112 (11): 3610.

https://doi.org/10.1182/blood.V112.11.3610.3610

Published: 2008

Journal Articles

Impact of Hematopoietic Cell Transplantation with Total Body Irradiation on the Health Status of Childhood Leukemia Survivors: A Report from the Childhood Cancer Survivor Study (CCSS).

K. Scott Baker, MD, Wendy Leisenring, ScD, Robert Hayashi, MD, Amanda Termuhlen, MD, Ann Mertens, PhD, Sarah Donaldson, MD, John Whitton, MS, Marilyn Stovall, PhD, Leslie Robison, PhD, Charles Sklar, MD

Blood (2005) 106 (11): 1109.

https://doi.org/10.1182/blood.V106.11.1109.1109

Published: 2005

NARROW

Antimetabolite dose intensity and adverse outcomes in children with acute lymphoblastic leukemia: a COG-AALL03N1 report

Poverty and relapse risk in children with acute lymphoblastic leukemia: a Children’s Oncology Group study AALL03N1 report

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Impact of 6 Mercaptopurine (6MP) Pill-Taking Habits on Adherence, Thioguanine Nucleotide (TGN) Levels and Relapse Risk in Children with Acute Lymphoblastic Leukemia (ALL): Results from a Children’s Oncology Group (COG) Study (AALL03N1)

High Intra-Individual Variability In Systemic Exposure To 6 Mercaptopurine (6MP) In Children With Acute Lymphoblastic Leukemia (ALL) Contributes To ALL Relapse: Results From a Children’s Oncology Group (COG) Study (AALL03N1)

Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia

Meta-Analysis of Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) with Comparison to a Historical Control (HC).

Defibrotide (DF) In the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF): Results of a Treatment IND Expanded Access Protocol

Defibrotide (DF) in the Treatment of Severe Hepatic Veno-Occlusive Disease (VOD) with Multi-Organ Failure (MOF) Following Stem Cell Transplantation (SCT): Results of a Phase 3 Study Utilizing a Historical Control.

High-Dose Methotrexate and Early Intensification of Therapy Do Not Improve 3 Year EFS in Children and Adolescents with Disseminated Lymphoblastic Lymphoma. Results of the Randomized Arms of COG A5971

Impact of Hematopoietic Cell Transplantation with Total Body Irradiation on the Health Status of Childhood Leukemia Survivors: A Report from the Childhood Cancer Survivor Study (CCSS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only